Researchers at Cedars-Sinai Health Sciences University have developed a long short-term memory artificial intelligence model capable of predicting hypoglycemia in hospitalized patients up to twenty-four hours in advance. Published in npj Digital Medicine, the tool addresses a critical gap in clinical care by shifting the management of low blood sugar from a reactive to a proactive model. Hypoglycemia remains a frequent and potentially life-threatening complication among inpatients, particularly for those receiving insulin therapy, undergoing preoperative fasting, or managing critical illnesses. Current clinical practice typically involves monitoring and treating blood sugar drops only after they occur, leaving patients vulnerable to severe outcomes such as seizures, coma, and cardiac arrhythmias. The predictive algorithm processes electronic health record data, capturing medication administration, laboratory results, nutritional intake, and relevant clinical metrics in four-hour intervals over a five-day window. By analyzing these temporal patterns, the model generates a twenty-four-hour risk forecast and highlights the specific physiological and treatment factors driving that probability. The development team, led by principal investigators Amanda Momenzadeh, PharmD, Jesse Meyer, PhD, and Roma Gianchandani, MD, trained and validated the system using historical records from over one hundred forty-three thousand adult admissions across three Cedars-Sinai facilities between 2014 and 2025. Subsequent prospective testing confirmed the model's real-time reliability and operational readiness. Clinical deployment of the tool is projected to prevent three to four hypoglycemic episodes per day at a single large medical center, with scalability offering substantial global health benefits. Because the system operates directly on routinely collected hospital data without requiring specialized hardware or additional patient monitoring, integration into existing electronic health record workflows is designed to be seamless. The framework aims to empower clinical decision support systems, enabling care teams to adjust insulin regimens, modify nutritional plans, or intensify monitoring before adverse events manifest. Experts emphasize that the model represents a functional advance in computational biomedicine rather than a theoretical exercise. By delivering actionable early warnings, the technology supports hospital diabetes management programs and contributes to broader patient safety initiatives. Widespread adoption could establish a new standard for data-driven inpatient care, reducing preventable complications and optimizing resource allocation across acute care settings.